ℹ️
🇬🇧
Search
Search for publications relevant for "Programmed death ligand 1"
Programmed death ligand 1
Publication
Class
Person
Publication
Programmes
publication
Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma
2019 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma
2022 |
First Faculty of Medicine, Faculty of Science
publication
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
2018 |
First Faculty of Medicine
publication
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens
2020 |
Publication without faculty affiliation
publication
Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: A randomized clinical trial
2023 |
Publication without faculty affiliation
publication
Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer
2022 |
Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer
2022 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Immunotherapy of triple negative breast cancer
2019 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
publication
The current standard of NSCLC pathological examination in the Czech Republic
2022 |
Faculty of Medicine in Hradec Králové
publication
Atypical response to anti-PD-1 therapy followed by long-term survival in non-small cell lung cancer - case reports
2020 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Studie IMpower110 a její výsledky
2021 |
First Faculty of Medicine
publication
Current procedures and news in the treatment of lung cancer
2021 |
First Faculty of Medicine
publication
Predictive markers in breast cancer
2021 |
First Faculty of Medicine
publication
The PD-L1-Associated Carcinogenesis May Encompass Oncogenes UHRF2 and PTPRD
Publication without faculty affiliation
publication
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
2019 |
First Faculty of Medicine
publication
Neopterin as a biomarker of immune response in cancer patients
2017 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Laboratory Parameters Associated with Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer
2022 |
Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
The prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma
2017 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature
2020 |
First Faculty of Medicine, Third Faculty of Medicine
publication
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
2020 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, Second Faculty of Medicine
publication
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation
2021 |
Faculty of Medicine in Hradec Králové
publication
Colonic Adenocarcinomas Harboring NTRK Fusion Genes A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature
2020 |
Faculty of Medicine in Pilsen
publication
Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer
2022 |
First Faculty of Medicine, Third Faculty of Medicine
publication
High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature
2020 |
Central Library of Charles University, Faculty of Medicine in Pilsen
publication
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
2017 |
Central Library of Charles University
publication
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
2019 |
Second Faculty of Medicine